CD274 and neoplasm: Strikingly, the PET signal uptake was highly correlated to patient response to treatment, as measured by RECIST categorization and Kaplan–Meier curves, and at a more significant degree compared to two separate FDA-approved tumor tissue PD-L1 immunohistochemistry methods, suggesting the potential of molecular imaging for the assessment of PD-L1 expression and treatment prognoses.